Status:
UNKNOWN
Topical Chamomile in Preventing Chemotherapy-induced Oral Mucositis
Lead Sponsor:
Hams Hamed Abdelrahman
Conditions:
Oral Mucositis Due to Chemotherapy
Eligibility:
All Genders
20-70 years
Phase:
PHASE2
Brief Summary
the main aim of this study is to clinically assess the effectiveness of topical chamomile oral gel in the prevention of chemotherapy-induced oral mucositis.
Detailed Description
The study was designed as a randomized, controlled, clinical trial. patients who were undergoing to receive chemotherapy were divided into three groups: Group I: was given conventional treatment. Grou...
Eligibility Criteria
Inclusion
- Patients who are going to receive 5-Fluoroucil (5-FU) based chemotherapy regime.
- Males and females with an age of not less than 20 years and not exceeding 70 years.
Exclusion
- 1\. Patients suffering from any uncontrolled systemic diseases that affect integrity of the epithelium (such as diabetes, cardiovascular, liver disorder and renal dysfunction) 2. Pregnant and lactating women 3. Patients with findings of any physical or mental abnormality which would interfere with or be affected by the study procedure
Key Trial Info
Start Date :
May 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 30 2020
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04317183
Start Date
May 15 2019
End Date
March 30 2020
Last Update
March 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Outpatient clinic of Department of Clinical Oncology, Faculty of Medicine
Alexandria, Egypt